ArticleInternational journal of molecular sciences2025
Marine- and Plant-Based Nanoemulsion Platforms Enhance the Anticancer Activity of Curcumin In Vitro.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curcumin is a natural bioactive compound with demonstrated anticancer activity. However, its poor aqueous solubility and limited bioavailability constrain its therapeutic utility. This study formulated nanoemulsions using marine (salmon oil) and plant (rapeseed oil) lipids to enhance the solubility and delivery of curcumin. The fatty acid profiles and lipid class distributions of both lipid sources were characterized. The resulting nanoemulsions prepared from salmon and rapeseed oils exhibited mean droplet diameters of approximately 170 nm and 220 nm, respectively, and remained physically stable for 30 days at 25 °C. Notably, curcumin-loaded nanoemulsions displayed smaller droplet sizes than their unloaded counterparts, suggesting strong curcumin-lecithin interactions. In vitro cytotoxicity assays demonstrated that the curcumin-loaded nanoemulsions significantly reduced the proliferation of MCF-7 human breast cancer cells (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.